DK167841B1 - Anvendelse af et 2-hydroxy-5-oe1-hydroxy-2-oeoe1-(p-methoxyphenyl)-prop-2-ylaa-aminoaa-ethylaa-formanilid eller et farmaceutisk anvendeligt salt deraf til fremstilling af et farmaceutisk praeparat til dermal behandling af betaendelsesagtige hudsygdomme - Google Patents

Anvendelse af et 2-hydroxy-5-oe1-hydroxy-2-oeoe1-(p-methoxyphenyl)-prop-2-ylaa-aminoaa-ethylaa-formanilid eller et farmaceutisk anvendeligt salt deraf til fremstilling af et farmaceutisk praeparat til dermal behandling af betaendelsesagtige hudsygdomme Download PDF

Info

Publication number
DK167841B1
DK167841B1 DK289487A DK289487A DK167841B1 DK 167841 B1 DK167841 B1 DK 167841B1 DK 289487 A DK289487 A DK 289487A DK 289487 A DK289487 A DK 289487A DK 167841 B1 DK167841 B1 DK 167841B1
Authority
DK
Denmark
Prior art keywords
hydroxy
active substance
methoxyphenyl
prop
formanilide
Prior art date
Application number
DK289487A
Other languages
Danish (da)
English (en)
Other versions
DK289487D0 (da
DK289487A (da
Inventor
Irmgaard Boettcher
Werner Pignat
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK289487D0 publication Critical patent/DK289487D0/da
Publication of DK289487A publication Critical patent/DK289487A/da
Application granted granted Critical
Publication of DK167841B1 publication Critical patent/DK167841B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK289487A 1986-06-05 1987-06-04 Anvendelse af et 2-hydroxy-5-oe1-hydroxy-2-oeoe1-(p-methoxyphenyl)-prop-2-ylaa-aminoaa-ethylaa-formanilid eller et farmaceutisk anvendeligt salt deraf til fremstilling af et farmaceutisk praeparat til dermal behandling af betaendelsesagtige hudsygdomme DK167841B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH229086 1986-06-05
CH229086 1986-06-05

Publications (3)

Publication Number Publication Date
DK289487D0 DK289487D0 (da) 1987-06-04
DK289487A DK289487A (da) 1987-12-06
DK167841B1 true DK167841B1 (da) 1993-12-27

Family

ID=4230316

Family Applications (1)

Application Number Title Priority Date Filing Date
DK289487A DK167841B1 (da) 1986-06-05 1987-06-04 Anvendelse af et 2-hydroxy-5-oe1-hydroxy-2-oeoe1-(p-methoxyphenyl)-prop-2-ylaa-aminoaa-ethylaa-formanilid eller et farmaceutisk anvendeligt salt deraf til fremstilling af et farmaceutisk praeparat til dermal behandling af betaendelsesagtige hudsygdomme

Country Status (10)

Country Link
US (1) US4975466A (fr)
EP (1) EP0252286B1 (fr)
JP (1) JPS6322015A (fr)
KR (1) KR880000091A (fr)
AU (1) AU614712B2 (fr)
CA (1) CA1305423C (fr)
DE (1) DE3780226D1 (fr)
DK (1) DK167841B1 (fr)
IE (1) IE59612B1 (fr)
PH (1) PH25150A (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416925A3 (en) * 1989-09-07 1991-09-25 Glaxo Group Limited Use of 4-hydroxy-alpha 1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation
US5434304A (en) * 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
US6866839B2 (en) * 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5135954A (en) * 1991-05-24 1992-08-04 The Regents Of The University Of California Use of formoterol for treatment of tissue injury
ES2195021T3 (es) * 1995-11-30 2003-12-01 Kissei Pharmaceutical Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis.
CA2264524A1 (fr) 1996-10-04 1998-04-09 Norihiro Shinkai Timbre percutane
DK0948357T3 (da) * 1996-12-13 2002-07-15 Alcon Lab Inc Anvendelse af aminoalkoholer med lav molekylevægt i oftalmiske sammensætninger
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
NZ540166A (en) 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
JP5108234B2 (ja) * 2005-02-07 2012-12-26 日本特殊陶業株式会社 マイクロヒータ及びセンサ
KR101355422B1 (ko) 2005-04-13 2014-02-06 아스션 팔마 에이/에스 피부 결합조직질환 치료용 베타-2 아드레노리셉터 작용제
MX2009000507A (es) * 2006-07-14 2009-06-12 Stiefel Res Australia Pty Ltd Espuma farmaceutica de acidos grasos.
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
WO2009090495A2 (fr) 2007-12-07 2009-07-23 Foamix Ltd. Vecteurs moussants siliconés à base d'huile et de liquide, et formulations
WO2010041141A2 (fr) 2008-10-07 2010-04-15 Foamix Ltd. Support expansible à base d’huile et préparations
CA2712120A1 (fr) 2008-01-14 2009-07-23 Foamix Ltd. Compositions pharmaceutiques pouvant mousser de poloxamere avec des agents actifs et/ou des cellules therapeutiques, et utilisations
US8735422B2 (en) * 2009-02-06 2014-05-27 Skinvisible Pharmaceuticals, Inc. Cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769625C (fr) 2009-07-29 2017-04-11 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses legeres, et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
DE2305092A1 (de) * 1972-02-05 1973-08-16 Yamanouchi Pharma Co Ltd Alpha-aminomethylbenzylalkoholderivate
DE2401450A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen
GB1531718A (en) * 1974-11-20 1978-11-08 Pharmacia As Phenylethanolamines
DK31578A (da) * 1977-02-03 1978-08-04 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af benzenderivater
JPS5592312A (en) * 1978-12-29 1980-07-12 Yamanouchi Pharmaceut Co Ltd Suppository containing bronchodilating compound
US4303637A (en) * 1980-04-04 1981-12-01 Alza Corporation Medication indicated for ocular hypertension
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤

Also Published As

Publication number Publication date
EP0252286A3 (en) 1990-01-17
EP0252286B1 (fr) 1992-07-08
US4975466A (en) 1990-12-04
AU614712B2 (en) 1991-09-12
JPS6322015A (ja) 1988-01-29
DK289487D0 (da) 1987-06-04
IE59612B1 (en) 1994-03-09
DK289487A (da) 1987-12-06
PH25150A (en) 1991-03-13
JPH0448774B2 (fr) 1992-08-07
IE871485L (en) 1987-12-05
DE3780226D1 (de) 1992-08-13
CA1305423C (fr) 1992-07-21
AU7383687A (en) 1987-12-10
EP0252286A2 (fr) 1988-01-13
KR880000091A (ko) 1988-03-23

Similar Documents

Publication Publication Date Title
DK167841B1 (da) Anvendelse af et 2-hydroxy-5-oe1-hydroxy-2-oeoe1-(p-methoxyphenyl)-prop-2-ylaa-aminoaa-ethylaa-formanilid eller et farmaceutisk anvendeligt salt deraf til fremstilling af et farmaceutisk praeparat til dermal behandling af betaendelsesagtige hudsygdomme
Amselem et al. Submicron emulsions as drug carriers for topical administration
US5837735A (en) Antiinflammatory agent for external use
CA3018969C (fr) Compositions pharmaceutiques a base d'apremilast
RU2381794C2 (ru) Содержащая амброксол композиция для местного применения
DE69327432T2 (de) Heilmittel für wunden und hämorrhoiden
EA020569B1 (ru) Применение рофлумиласта и его производных и фармацевтический препарат для местного применения
JP2853902B2 (ja) プロスタサイクリン類を活性成分として含有する外用皮膚血流量増加剤
KR20100099191A (ko) 수술전 처리
JP2000515498A (ja) 抗ヒスタミン化合物とテルペノイド化合物の組み合わせからなる局所組成物
JP2005513139A (ja) 乾癬及び他の皮膚疾患の治療のための製薬組成物
KR20130119958A (ko) 피부 회복을 위한 조성물 및 방법
JP2013512275A (ja) Ｈｉｖ感染予防用ヒドロキシチロソール及び誘導体の局所使用
JP2022188061A (ja) Ｖｅｇｆ阻害剤の局所投与による皮膚障害の処置
JP2646025B2 (ja) コルチコステロイド含有ローション剤
US4868192A (en) Pharmaceutical compositions and methods using certain 4H-pyrano (3,2-g) quinoline compounds
US5817675A (en) Compositions for the treatment of psoriasis and their use
KR20010071319A (ko) 미녹시딜 함유 외용 조성물
JPH05194219A (ja) 局所用抗かび剤
US4871767A (en) Medicament preparations
JP2010513424A (ja) 炎症性免疫アレルギー成分を含みうる角化障害に関連した皮膚病変の治療のためのネパフェナクまたはその誘導体の使用
WO2016159351A1 (fr) Système d'administration de médicament destiné à cibler une glande lacrymale
JPS58167510A (ja) インドメタシン含有パツプ剤
JPH05271226A (ja) 創傷治癒促進剤
RU2426540C1 (ru) Противовоспалительное и противоаллергическое лекарственное средство и фармацевтическая композиция на его основе

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed